Notably, a consistent positive correlation was observed between ZNF668 expression and MSI in several cancer types, including BRCA, CESC, GBM, HNSC, KICH, KIRC, LUAD, LUSC, and PRAD (Figure 5E). This evidence concerns the gene ZNF668 and glioblastoma.